Search - tctmd.com

Displaying 1 - 20 of 295

Sort: Relevancy | Date

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation TCT India 2025

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

Presenter: Sundeep Mishra

July 27, 2025

Presentation TCT India 2025

ULC PCI with IVUS

Presenter: Ashish Pershad

July 26, 2025

Presentation TCT India 2025

Hybrid approach to Complex PCI

Presenter: Sandeep Parekh

July 26, 2025

Presentation Miami Valves 2024

Optimizing Bifurcation LM PCI Strategy and Outcomes

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

Presenter: Ruthvik Srinivasamurthy

February 03, 2024

Presentation Cardiovascular Interventions 2023

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation Cardiovascular Interventions 2023

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

Presenter: Paul S. Teirstein

November 10, 2023

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation SCAD 2022

Indications for PCI and Strategies

Presenter: Jennifer A. Tremmel

February 19, 2022

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation

Association of Sex With Outcomes in Patients Undergoing PCI

January 31, 2020

Presentation

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

January 15, 2020

Presentation

Outcomes of Fractional Flow Reserve-Guided PCI in Patients with ACS

December 05, 2019

Presentation TCT Abstracts Posters 2019

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Presenter: Jihoon Kim

October 03, 2019

Advertisement

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

How do we predict risk in complex/high-risk PCI? Using scores and paradigms effectively

ULC PCI with IVUS

Hybrid approach to Complex PCI

Optimizing Bifurcation LM PCI Strategy and Outcomes

Impella Assisted Bifurcation PCI of Severely Calcified Unprotected LM using RotaShock Technique

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Indications for PCI and Strategies

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Optimal LDL levels in patients with ACS undergoing PCI

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Association of Sex With Outcomes in Patients Undergoing PCI

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

Outcomes of Fractional Flow Reserve-Guided PCI in Patients with ACS

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content